Willicia Toran
Psychiatric/Mental Health · Houston, TXNPI 1114645595
Payments from drug & device makers
Across 173 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$655
- Otsuka America Pharmaceutical, Inc.$586
- AbbVie$543
- Indivior Inc.$317
- Lundbeck LLC$191
- Neurocrine Biosciences, Inc.$183
- plus $974 from 12 others
What the payments were for
- Food & beverage$3,440100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 26 | $655 |
| Otsuka America Pharmaceutical, Inc. | 24 | $586 |
| AbbVie | 41 | $543 |
| Indivior Inc. | 17 | $317 |
| Lundbeck LLC | 11 | $191 |
| Neurocrine Biosciences, Inc. | 11 | $183 |
| Teva Pharmaceuticals USA, Inc. | 9 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $154 |
| Corium, LLC | 6 | $139 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Supernus Pharmaceuticals, Inc. | 4 | $87 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $80 |
| Alkermes, Inc. | 3 | $79 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$237
- REXULTI$122
- COBENFY$120
- INVEGA TRINZA$112
How this compares
$3,448 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 36 | $1,545 |
| Trazodone Hcl | 62 | $397 |
| Hydroxyzine Hcl | 20 | $377 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 17 | $328 |
| Bupropion XlBupropion Hcl | 30 | $308 |
| Olanzapine | 14 | $210 |
| Fluoxetine Hcl | 26 | $200 |
| Zolpidem Tartrate | 28 | $197 |
| Buspirone Hcl | 30 | $180 |
| Sertraline Hcl | 23 | $155 |
| Eszopiclone | 12 | $152 |
| Quetiapine Fumarate | 25 | $134 |
| Propranolol Hcl | 14 | $134 |
| Topiramate | 13 | $125 |
| Risperidone | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Houston
- Natalie TellezHouston$602K
- Britney PridgenHouston$57K
- Linzi LeightonHouston$16K
- Samantha SharpeHouston$14K
- Jennifer RobinsonHouston$12K
- Tracy HicksLongview$684K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.